Terms: = Lymphoma AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Clinical Outcome
18 results:
1. Phenotype, Function, and clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone lymphoma.
Tang X; Yang ZZ; Kim HJ; Anagnostou T; Yu Y; Wu X; Chen J; Krull JE; Wenzl K; Mondello P; Bhardwaj V; Wang J; Novak AJ; Ansell SM
Clin Cancer Res; 2022 Oct; 28(19):4322-4335. PubMed ID: 35686915
[TBL] [Abstract] [Full Text] [Related]
2. Elevated serum IL-13 level is associated with increased Treg cells in tumor microenvironment and disease progression of diffuse large B-cell lymphoma.
Li X; Liu M; Shi Q; Fang Y; Fu D; Shen ZX; Yi H; Wang L; Zhao W
Hematol Oncol; 2023 Apr; 41(2):230-238. PubMed ID: 35304777
[TBL] [Abstract] [Full Text] [Related]
3. Anthracycline-based consolidation may determine outcome of post-consolidation immunotherapy in AML.
Aurelius J; Möllgård L; Kiffin R; Ewald Sander F; Nilsson S; Thorén FB; Hellstrand K; Martner A
Leuk Lymphoma; 2019 Nov; 60(11):2771-2778. PubMed ID: 30991860
[TBL] [Abstract] [Full Text] [Related]
4. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.
Grauers Wiktorin H; Nilsson MS; Kiffin R; Sander FE; Lenox B; Rydström A; Hellstrand K; Martner A
Cancer Immunol Immunother; 2019 Feb; 68(2):163-174. PubMed ID: 30315349
[TBL] [Abstract] [Full Text] [Related]
5. IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.
Mao Y; van Hoef V; Zhang X; Wennerberg E; Lorent J; Witt K; Masvidal L; Liang S; Murray S; Larsson O; Kiessling R; Lundqvist A
Blood; 2016 Sep; 128(11):1475-89. PubMed ID: 27465917
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy and safety of adoptive immunotherapy using anti-CD19 chimeric antigen receptor transduced T-cells: a systematic review of phase I clinical trials.
Xu XJ; Zhao HZ; Tang YM
Leuk Lymphoma; 2013 Feb; 54(2):255-60. PubMed ID: 22897728
[TBL] [Abstract] [Full Text] [Related]
7. Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial.
Olioso P; Giancola R; Di Riti M; Contento A; Accorsi P; Iacone A
Hematol Oncol; 2009 Sep; 27(3):130-9. PubMed ID: 19294626
[TBL] [Abstract] [Full Text] [Related]
8. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
He L; Li D; Hou KZ; Liu YP
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
[TBL] [Abstract] [Full Text] [Related]
9. Serological immunomarkers in cutaneous T cell lymphoma.
Hassel JC; Meier R; Joller-Jemelka H; Burg G; Dummer R
Dermatology; 2004; 209(4):296-300. PubMed ID: 15539892
[TBL] [Abstract] [Full Text] [Related]
10. Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.
Eisterer W; Bechter O; Söderberg O; Nilsson K; Terol M; Greil R; Thaler J; Herold M; Finke L; Günthert U; Montserrat E; Stauder R
Leuk Res; 2004 Oct; 28(10):1043-51. PubMed ID: 15289016
[TBL] [Abstract] [Full Text] [Related]
11. Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. clinical significance of interleukin-10 serum levels for Hodgkin's disease.
Bohlen H; Kessler M; Sextro M; Diehl V; Tesch H
Ann Hematol; 2000 Mar; 79(3):110-3. PubMed ID: 10803931
[TBL] [Abstract] [Full Text] [Related]
12. The immunobiology of low-dose total-body irradiation: more questions than answers.
Safwat A
Radiat Res; 2000 May; 153(5 Pt 1):599-604. PubMed ID: 10790282
[TBL] [Abstract] [Full Text] [Related]
13. Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma.
Schmidt-Wolf IG; Finke S; Trojaneck B; Denkena A; Lefterova P; Schwella N; Heuft HG; Prange G; Korte M; Takeya M; Dorbic T; Neubauer A; Wittig B; Huhn D
Br J Cancer; 1999 Nov; 81(6):1009-16. PubMed ID: 10576658
[TBL] [Abstract] [Full Text] [Related]
14. Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosis.
Ito C; Kumagai M; Manabe A; Coustan-Smith E; Raimondi SC; Behm FG; Murti KG; Rubnitz JE; Pui CH; Campana D
Blood; 1999 Jan; 93(1):315-20. PubMed ID: 9864176
[TBL] [Abstract] [Full Text] [Related]
15. clinical importance of interleukin-2 receptor alpha-chain expression in acute leukemia. The Japan Cooperative Group of Leukemia/lymphoma.
Nakase K; Kita K; Kageyama S; Tsuji K; Miyanishi E; Miwa H; Tanaka I; Shirakawa S; Tanaka I; Anazawa H; Tsutani H; Kyo T; Dohy H; Kamada N; Doi S; Nasu K; Uchino H
Cancer Detect Prev; 1997; 21(3):273-9. PubMed ID: 9167045
[TBL] [Abstract] [Full Text] [Related]
16. clinical and immunological studies in advanced cancer patients sequentially treated with anti CD3 monoclonal antibody (OKT3) and interleukin-2.
Borrione P; Montacchini L; Beggiato E; Pileri A; Bianchi A; Massaia M
Leuk Lymphoma; 1996 Apr; 21(3-4):325-30. PubMed ID: 8726415
[TBL] [Abstract] [Full Text] [Related]
17. Effect of low-dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation.
Soiffer RJ; Murray C; Gonin R; Ritz J
Blood; 1994 Aug; 84(3):964-71. PubMed ID: 8043878
[TBL] [Abstract] [Full Text] [Related]
18. Biological monitoring of low-dose interleukin 2 in humans: soluble interleukin 2 receptors, cytokines, and cell surface phenotypes.
Hänninen EL; Körfer A; Hadam M; Schneekloth C; Dallmann I; Menzel T; Kirchner H; Poliwoda H; Atzpodien J
Cancer Res; 1991 Dec; 51(23 Pt 1):6312-6. PubMed ID: 1933892
[TBL] [Abstract] [Full Text] [Related]
